"FDA has received a significant number of inquiries from members of 
the public and the health care community in response to this order to 
ECT manufacturers. In recognition of this significant public interest,
FDA is opening this docket to permit individuals other than 
manufacturers to submit information related to the safety and 
effectiveness of ECT."

<http://www.gpo.gov/fdsys/pkg/FR-2009-09-10/html/E9-21807.htm>http://www.gpo.gov/fdsys/pkg/FR-2009-09-10/html/E9-21807.htm 

or
http://bit.ly/5mHC6

Make public comments here:

<http://www.regulations.gov/search/Regs/home.html#submitComment?R=0900006480a20202>http://www.regulations.gov/search/Regs/home.html#submitComment?R=0900006480a20202 

or
http://bit.ly/Y2GSK

Comment here about adverse affects:

<https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm>https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm 


Comments to date:

http://www.regulations.gov/search/Regs/home.html#docketDetail?R=FDA-2009-N-0392

I added some shorter links in case you'd like to send this 
information to your networks.

Sylvia



Powered by LSoft's LISTSERV(R) list management software